PROCEPT BioRobotics Corp (PRCT) stock
PRCTNasdaqSurgical & Medical Instruments & ApparatusFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Nov 4, 2026Score 9/3051% below fair value
$23.51+0.17 (+0.73%)
Close on Nov 12, 2026Market cap $1.35BP/E –Yield –
PROCEPT BioRobotics ebitda
EBITDA is earnings before interest, taxes, depreciation and amortization, a rough measure of cash profit from operations.
PROCEPT BioRobotics's ebitda for the twelve months ending Sep 30, 2026 was -$110.44M. For fiscal 2025 it was -$97.47M. The highest annual figure on record is -$44.94M in fiscal 2020.
Annual ebitda
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | -$97.47M | – |
| FY2024 | Dec 31, 2024 | -$91.38M | – |
| FY2023 | Dec 31, 2023 | -$105.36M | – |
| FY2022 | Dec 31, 2022 | -$77.88M | – |
| FY2021 | Dec 31, 2021 | -$50.84M | – |
| FY2020 | Dec 31, 2020 | -$44.94M | – |
Quarterly ebitda
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q3 FY2026 | Sep 30, 2026 | -$24.84M | – |
| Q2 FY2026 | Jun 30, 2026 | -$25.40M | – |
| Q1 FY2026 | Mar 31, 2026 | -$30.87M | – |
| Q4 FY2025 | Dec 31, 2025 | -$29.33M | – |
| Q3 FY2025 | Sep 30, 2025 | -$21.57M | – |
| Q2 FY2025 | Jun 30, 2025 | -$20.60M | – |
| Q1 FY2025 | Mar 31, 2025 | -$25.96M | – |
| Q4 FY2024 | Dec 31, 2024 | -$18.26M | – |
| Q3 FY2024 | Sep 30, 2024 | -$21.10M | – |
| Q2 FY2024 | Jun 30, 2024 | -$25.56M | – |
| Q1 FY2024 | Mar 31, 2024 | -$26.47M | – |
| Q4 FY2023 | Dec 31, 2023 | -$28.24M | – |
| Q3 FY2023 | Sep 30, 2023 | -$24.56M | – |
| Q2 FY2023 | Jun 30, 2023 | -$24.98M | – |
| Q1 FY2023 | Mar 31, 2023 | -$27.58M | – |
| Q4 FY2022 | Dec 31, 2022 | -$24.38M | – |
| Q3 FY2022 | Sep 30, 2022 | -$21.40M | – |
| Q2 FY2022 | Jun 30, 2022 | -$17.16M | – |
| Q1 FY2022 | Mar 31, 2022 | -$14.95M | – |
| Q4 FY2021 | Dec 31, 2021 | -$16.07M | – |
| Q3 FY2021 | Sep 30, 2021 | -$12.00M | – |
| Q2 FY2021 | Jun 30, 2021 | -$12.34M | – |
| Q1 FY2021 | Mar 31, 2021 | -$10.43M | – |
| Q4 FY2020 | Dec 31, 2020 | -$12.49M | – |
See a number that looks wrong?